These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31540142)

  • 1. Association of Antihyperglycemic Therapy with Risk of Atrial Fibrillation and Stroke in Diabetic Patients.
    Lăcătușu CM; Grigorescu ED; Stătescu C; Sascău RA; Onofriescu A; Mihai BM
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus.
    Fauchier L; Boriani G; de Groot JR; Kreutz R; Rossing P; Camm AJ
    Europace; 2021 Dec; 23(12):1873-1891. PubMed ID: 34411235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antidiabetic drugs on the risk of atrial fibrillation: mechanistic insights from clinical evidence and translational studies.
    Lee TW; Lee TI; Lin YK; Chen YC; Kao YH; Chen YJ
    Cell Mol Life Sci; 2021 Feb; 78(3):923-934. PubMed ID: 32965513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the loire valley atrial fibrillation project.
    Lip GYH; Clementy N; Pierre B; Boyer M; Fauchier L
    Chest; 2015 Apr; 147(4):1103-1110. PubMed ID: 25412290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study.
    Liou YS; Yang FY; Chen HY; Jong GP
    PLoS One; 2018; 13(8):e0197245. PubMed ID: 30161122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    Yonsei Med J; 2015 Jan; 56(1):62-71. PubMed ID: 25510748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies.
    Chang SH; Wu LS; Chiou MJ; Liu JR; Yu KH; Kuo CF; Wen MS; Chen WJ; Yeh YH; See LC
    Cardiovasc Diabetol; 2014 Aug; 13():123. PubMed ID: 25106079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients.
    Marfella R; Sasso FC; Siniscalchi M; Cirillo M; Paolisso P; Sardu C; Barbieri M; Rizzo MR; Mauro C; Paolisso G
    J Am Coll Cardiol; 2013 Aug; 62(6):525-30. PubMed ID: 23684685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus.
    Moss AS; Dimitropoulos G; Connolly DL; Lip GYH
    Expert Opin Pharmacother; 2017 Aug; 18(11):1101-1114. PubMed ID: 28669216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis.
    Zhang Z; Zhang X; Korantzopoulos P; Letsas KP; Tse G; Gong M; Meng L; Li G; Liu T
    BMC Cardiovasc Disord; 2017 Apr; 17(1):96. PubMed ID: 28381265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
    Ovalle F
    Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).
    Bansilal S; Bloomgarden Z; Halperin JL; Hellkamp AS; Lokhnygina Y; Patel MR; Becker RC; Breithardt G; Hacke W; Hankey GJ; Nessel CC; Singer DE; Berkowitz SD; Piccini JP; Mahaffey KW; Fox KA;
    Am Heart J; 2015 Oct; 170(4):675-682.e8. PubMed ID: 26386791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Diabetes Mellitus on Stroke and Survival in Patients With Atrial Fibrillation.
    Patlolla SH; Lee HC; Noseworthy PA; Wysokinski WE; Hodge DO; Greene EL; Gersh BJ; Melduni RM
    Am J Cardiol; 2020 Sep; 131():33-39. PubMed ID: 32723556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study.
    Pallisgaard JL; Lindhardt TB; Staerk L; Olesen JB; Torp-Pedersen C; Hansen ML; Gislason GH
    Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):140-146. PubMed ID: 28028073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex interplay between diabetes mellitus and atrial fibrillation.
    Yildiz M; Lavie CJ; Morin DP; Oktay AA
    Expert Rev Cardiovasc Ther; 2022 Sep; 20(9):707-717. PubMed ID: 35984314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcome in type 2 diabetes and atrial fibrillation.
    Costard-Jäckle A; Tschöpe D; Meinertz T
    Herz; 2019 Sep; 44(6):522-525. PubMed ID: 29721589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies.
    Bell DSH; Goncalves E
    Diabetes Obes Metab; 2019 Feb; 21(2):210-217. PubMed ID: 30144274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.